Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-γ in the same cell

Efficient MHC expression and inhibition of tumor and metastasis growth

P. L. Lollini, C. De Giovanni, L. Landuzzi, G. Nicoletti, F. Frabetti, F. Cavallo, M. Giovarelli, G. Forni, A. Modica, A. Modesti, P. Musiani, P. Nanni

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The mouse mammary carcinoma TS/A, of BALB/c (H-2d) origin, was transfected with the murine interferon-γ (IFN-γ) gene (Int. J. Cancer 55: 320, 1993). We used IFN-γ transfectants as recipients for a second round of transfections with murine allogeneic class I histocompatibility (H-2b) genes that are modulated by IFN. Transfectants with either gene alone, as well as parent TS/A cells (TS/A-pc), were used as controls. Only double transfectants expressed high levels of the allogeneic H-2b genes, while in H-2b single transfectants the expression was very low (but was induced by treatment with exogenous IFN-γ). The tumorigenic potential of IFN-γ or H-2b single transfectants was reduced in comparison to TS/A-pc. IFN-γ + H-2Kb double transfectants were almost nontumorigenic, while IFN-γ + H-2Db clones gave rise to tumors in about one-half of mice. The experimental metastatic ability of all IFN-γ + H-2b double transfectants was very low. IFN-γ single transfectants were known to induce a strong macrophage response in the host. The expression of allogeneic H-2 antigens added a T-lymphocyte-mediated response that accounted for the lower tumorigenicity of double transfectants. These results show that it is possible to steer the immune response evoked by tumor cells for therapeutic purposes. Moreover, the high H-2 expression obtained in IFN-γ + H-2b double transfectants suggests that single IFN-γ transfectants are ideal recipients for all IFN-sensitive genes. This approach can be used also for other general-purpose inducers of gene expression.

Original languageEnglish
Pages (from-to)743-752
Number of pages10
JournalHuman Gene Therapy
Volume6
Issue number6
Publication statusPublished - Jun 1995

Fingerprint

Interferon Inducers
Histocompatibility Antigens
Interferons
Neoplasm Metastasis
Growth
Genes
Neoplasms
H-2 Antigens
Histocompatibility
Transfection

ASJC Scopus subject areas

  • Genetics

Cite this

Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-γ in the same cell : Efficient MHC expression and inhibition of tumor and metastasis growth. / Lollini, P. L.; De Giovanni, C.; Landuzzi, L.; Nicoletti, G.; Frabetti, F.; Cavallo, F.; Giovarelli, M.; Forni, G.; Modica, A.; Modesti, A.; Musiani, P.; Nanni, P.

In: Human Gene Therapy, Vol. 6, No. 6, 06.1995, p. 743-752.

Research output: Contribution to journalArticle

Lollini, P. L. ; De Giovanni, C. ; Landuzzi, L. ; Nicoletti, G. ; Frabetti, F. ; Cavallo, F. ; Giovarelli, M. ; Forni, G. ; Modica, A. ; Modesti, A. ; Musiani, P. ; Nanni, P. / Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-γ in the same cell : Efficient MHC expression and inhibition of tumor and metastasis growth. In: Human Gene Therapy. 1995 ; Vol. 6, No. 6. pp. 743-752.
@article{a01c3325a30e44af9a000e74a8232321,
title = "Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-γ in the same cell: Efficient MHC expression and inhibition of tumor and metastasis growth",
abstract = "The mouse mammary carcinoma TS/A, of BALB/c (H-2d) origin, was transfected with the murine interferon-γ (IFN-γ) gene (Int. J. Cancer 55: 320, 1993). We used IFN-γ transfectants as recipients for a second round of transfections with murine allogeneic class I histocompatibility (H-2b) genes that are modulated by IFN. Transfectants with either gene alone, as well as parent TS/A cells (TS/A-pc), were used as controls. Only double transfectants expressed high levels of the allogeneic H-2b genes, while in H-2b single transfectants the expression was very low (but was induced by treatment with exogenous IFN-γ). The tumorigenic potential of IFN-γ or H-2b single transfectants was reduced in comparison to TS/A-pc. IFN-γ + H-2Kb double transfectants were almost nontumorigenic, while IFN-γ + H-2Db clones gave rise to tumors in about one-half of mice. The experimental metastatic ability of all IFN-γ + H-2b double transfectants was very low. IFN-γ single transfectants were known to induce a strong macrophage response in the host. The expression of allogeneic H-2 antigens added a T-lymphocyte-mediated response that accounted for the lower tumorigenicity of double transfectants. These results show that it is possible to steer the immune response evoked by tumor cells for therapeutic purposes. Moreover, the high H-2 expression obtained in IFN-γ + H-2b double transfectants suggests that single IFN-γ transfectants are ideal recipients for all IFN-sensitive genes. This approach can be used also for other general-purpose inducers of gene expression.",
author = "Lollini, {P. L.} and {De Giovanni}, C. and L. Landuzzi and G. Nicoletti and F. Frabetti and F. Cavallo and M. Giovarelli and G. Forni and A. Modica and A. Modesti and P. Musiani and P. Nanni",
year = "1995",
month = "6",
language = "English",
volume = "6",
pages = "743--752",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-γ in the same cell

T2 - Efficient MHC expression and inhibition of tumor and metastasis growth

AU - Lollini, P. L.

AU - De Giovanni, C.

AU - Landuzzi, L.

AU - Nicoletti, G.

AU - Frabetti, F.

AU - Cavallo, F.

AU - Giovarelli, M.

AU - Forni, G.

AU - Modica, A.

AU - Modesti, A.

AU - Musiani, P.

AU - Nanni, P.

PY - 1995/6

Y1 - 1995/6

N2 - The mouse mammary carcinoma TS/A, of BALB/c (H-2d) origin, was transfected with the murine interferon-γ (IFN-γ) gene (Int. J. Cancer 55: 320, 1993). We used IFN-γ transfectants as recipients for a second round of transfections with murine allogeneic class I histocompatibility (H-2b) genes that are modulated by IFN. Transfectants with either gene alone, as well as parent TS/A cells (TS/A-pc), were used as controls. Only double transfectants expressed high levels of the allogeneic H-2b genes, while in H-2b single transfectants the expression was very low (but was induced by treatment with exogenous IFN-γ). The tumorigenic potential of IFN-γ or H-2b single transfectants was reduced in comparison to TS/A-pc. IFN-γ + H-2Kb double transfectants were almost nontumorigenic, while IFN-γ + H-2Db clones gave rise to tumors in about one-half of mice. The experimental metastatic ability of all IFN-γ + H-2b double transfectants was very low. IFN-γ single transfectants were known to induce a strong macrophage response in the host. The expression of allogeneic H-2 antigens added a T-lymphocyte-mediated response that accounted for the lower tumorigenicity of double transfectants. These results show that it is possible to steer the immune response evoked by tumor cells for therapeutic purposes. Moreover, the high H-2 expression obtained in IFN-γ + H-2b double transfectants suggests that single IFN-γ transfectants are ideal recipients for all IFN-sensitive genes. This approach can be used also for other general-purpose inducers of gene expression.

AB - The mouse mammary carcinoma TS/A, of BALB/c (H-2d) origin, was transfected with the murine interferon-γ (IFN-γ) gene (Int. J. Cancer 55: 320, 1993). We used IFN-γ transfectants as recipients for a second round of transfections with murine allogeneic class I histocompatibility (H-2b) genes that are modulated by IFN. Transfectants with either gene alone, as well as parent TS/A cells (TS/A-pc), were used as controls. Only double transfectants expressed high levels of the allogeneic H-2b genes, while in H-2b single transfectants the expression was very low (but was induced by treatment with exogenous IFN-γ). The tumorigenic potential of IFN-γ or H-2b single transfectants was reduced in comparison to TS/A-pc. IFN-γ + H-2Kb double transfectants were almost nontumorigenic, while IFN-γ + H-2Db clones gave rise to tumors in about one-half of mice. The experimental metastatic ability of all IFN-γ + H-2b double transfectants was very low. IFN-γ single transfectants were known to induce a strong macrophage response in the host. The expression of allogeneic H-2 antigens added a T-lymphocyte-mediated response that accounted for the lower tumorigenicity of double transfectants. These results show that it is possible to steer the immune response evoked by tumor cells for therapeutic purposes. Moreover, the high H-2 expression obtained in IFN-γ + H-2b double transfectants suggests that single IFN-γ transfectants are ideal recipients for all IFN-sensitive genes. This approach can be used also for other general-purpose inducers of gene expression.

UR - http://www.scopus.com/inward/record.url?scp=0029087684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029087684&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 743

EP - 752

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 6

ER -